COMBINING CISPLATIN AND CARBOPLATIN COMPLEMENTARY OR CONTRADICTORY

被引：12

作者：

CALVERT, AH

机构：

来源：

ANNALS OF ONCOLOGY | 1991年 / 2卷 / 02期

关键词：

D O I：

10.1093/oxfordjournals.annonc.a057889

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：89 / 91

页数：3

共 19 条

[1] EARLY CLINICAL-STUDIES WITH CIS-DIAMMINE-1,1-CYCLOBUTANE DICARBOXYLATE PLATINUM-II [J].

CALVERT, AH ;

HARLAND, SJ ;

NEWELL, DR ;

SIDDIK, ZH ;

JONES, AC ;

MCELWAIN, TJ ;

RAJU, S ;

WILTSHAW, E ;

SMITH, IE ;

BAKER, JM ;

PECKHAM, MJ ;

HARRAP, KR .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (03) :140-147

[2] CARBOPLATIN DOSAGE - PROSPECTIVE EVALUATION OF A SIMPLE FORMULA BASED ON RENAL-FUNCTION [J].

CALVERT, AH ;

NEWELL, DR ;

GUMBRELL, LA ;

OREILLY, S ;

BURNELL, M ;

BOXALL, FE ;

SIDDIK, ZH ;

JUDSON, IR ;

GORE, ME ;

WILTSHAW, E .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (11) :1748-1756

[3]

EGORIN MJ, 1984, CANCER RES, V44, P5432

[4]

EVANS BD, 1983, CANCER TREAT REP, V67, P997

[5] DOSE-ESCALATION STUDY OF CARBOPLATIN (DAY-1) AND CISPLATIN (DAY-3) - TOLERANCE AND RELATION TO LEUKOCYTE AND BUCCAL CELL PLATINUM DNA ADDUCTS [J].

GILL, I ;

MUGGIA, FM ;

TERHEGGEN, PMAB ;

MICHAEL, C ;

PARKER, RJ ;

KORTES, V ;

GRUNBERG, S ;

CHRISTIAN, MC ;

REED, E ;

DENENGELSE, L .

ANNALS OF ONCOLOGY, 1991, 2 (02) :115-121

[6] CISPLATIN CARBOPLATIN CROSS-RESISTANCE IN OVARIAN-CANCER [J].

GORE, ME ;

FRYATT, I ;

WILTSHAW, E ;

DAWSON, T ;

ROBINSON, BA ;

CALVERT, AH .

BRITISH JOURNAL OF CANCER, 1989, 60 (05) :767-769

[7] HIGH-DOSE CARBOPLATIN IN THE TREATMENT OF LUNG-CANCER AND MESOTHELIOMA - A PHASE-I DOSE ESCALATION STUDY [J].

GORE, ME ;

CALVERT, AH ;

SMITH, IE .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (09) :1391-1397

[8] CISPLATIN AND CARBOPLATIN IN COMBINATION FOR THE TREATMENT OF STAGE-IV OVARIAN-CARCINOMA [J].

HARDY, JR ;

WILTSHAW, E ;

BLAKE, PR ;

HARPER, P ;

SLEVIN, M ;

PERREN, TJ ;

TAN, S .

ANNALS OF ONCOLOGY, 1991, 2 (02) :131-136

[9]

HARLAND SJ, 1984, CANCER RES, V44, P1693

[10]

Hryniuk W M, 1988, Important Adv Oncol, P121

← 1 2 →